Thrombolytics for Cardiac Arrest: Case Report and Systematic Review of Controlled Trials

@article{Perrott2010ThrombolyticsFC,
  title={Thrombolytics for Cardiac Arrest: Case Report and Systematic Review of Controlled Trials},
  author={Jerrold L Perrott and Ryan J Henneberry and Peter J. Zed},
  journal={Annals of Pharmacotherapy},
  year={2010},
  volume={44},
  pages={2007 - 2013}
}
Objective: To describe a successful case involving the use of tenecteplase during cardiac arrest for presumed pulmonary embolism (PE) and to systematically review the evidence from controlled trials supporting the efficacy and safety of thrombolysis during cardiac arrest. Case Summary: A 48-year-old male presented to the emergency department with an acute onset of shortness of breath that began approximately 2 hours prior to presentation. Prior to undergoing a computed tomography (CT) scan to… 

Figures from this paper

Successful Alteplase Bolus Administration for a Presumed Massive Pulmonary Embolism During Cardiopulmonary Resuscitation
TLDR
Data from retrospective analyses, case series, and case reports suggest that various fibrinolytic regimens may facilitate ROSC and improve neurologically intact survival without an increased risk of fatal hemorrhage.
Intra-cardiac arrest thrombolysis in the pre-hospital setting: four cases worth considering
TLDR
A case series of four victims of OHCA who received thrombolysis, with adjunctive antithrombotic therapy, in the pre-hospital phase of their treatment is presented.
Pulmonary embolism with cardiac arrest: a STEMI patient's unexpected course.
We describe the successful use and complications of bolus-dose alteplase to treat strongly suspected pulmonary embolism (PE) with cardiac arrest in a patient initially presenting as ST-elevation
Thrombolysis during Extended Cardiopulmonary Resuscitation for Autoimmune-Related Pulmonary Embolism
TLDR
It is regarded that once there is presumptive diagnosis of MPE, initiating early thrombolysis during cardiopulmonary resuscitation may be considered.
Outcome of out-of-hospital cardiac arrest after fibrinolysis with reteplase in comparison to the return of spontaneous circulation after cardiac arrest score in a geographic region without emergency coronary intervention.
TLDR
For the analysed small patient collective, pre-hospital r-PA did not offer any benefits with regard to the ROSC rate, and analyses of larger patient numbers on a nationwide registry basis are recommended.
Complications of Cardiopulmonary Resuscitation
The surgeon is most likely to encounter a patient who has sustained a cardiac arrest in a hospital environment, where adequate monitoring will be in place and support personnel competent to initiate
Does Thrombolysis Have a Place in the Cardiopulmonary Resuscitation of Patients With Acute Pulmonary Embolism? A Case of Successful Thrombolysis During Pulmonary Embolism Induced Cardiopulmonary Arrest
TLDR
As bedside echocardiographic technology becomes more rapidly and readily available, the rapid diagnosis of pulmonary embolism and use of thrombolytics during cardiopulmonary resuscitation may need to be more routinely considered a potential therapeutic adjunctive measure.
A case of survival after cardiac arrest and 3½ hours of resuscitation.
TLDR
To the authors' knowledge, this is the only reported case in which a patient survived with good neurologic outcomes after a resuscitation that lasted as long as 3½ hours, and was bridged from dual ventricular assist devices to a total artificial heart.
Management dilemmas in acute pulmonary embolism
TLDR
Management dilemmas discussed include sub-massive PE, PE following recent stroke or surgery, thrombolysis dosing and use in cardiac arrest, surgical or catheter-based therapy, failure to respond to initial thrombosis, PE in pregnancy, right atrial thrombus and novel oral anticoagulants.
Drugs during cardiopulmonary resuscitation
  • P. Morley
  • Medicine, Biology
    Current opinion in critical care
  • 2011
TLDR
This review aims to highlight recently published articles that relate to the use of drugs during cardiopulmonary resuscitation (CPR), including epinephrine, which can be recommended in cardiac arrest, but only on the basis of short-term benefits.
...
1
2
3
...

References

SHOWING 1-10 OF 61 REFERENCES
Thrombolysis during resuscitation for out-of-hospital cardiac arrest.
TLDR
When tenecteplase was used without adjunctive antithrombotic therapy during advanced life support for out-of-hospital cardiac arrest, it did not detect an improvement in outcome, in comparison with placebo.
Low-dose tenecteplase during cardiopulmonary resuscitation due to massive pulmonary embolism: a case report and review of previously reported cases.
  • D. Hefer, A. Munir, H. Khouli
  • Medicine
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
  • 2007
TLDR
This is the first report to show that the use of a low dose of tenecteplase might be useful to achieve the return of spontaneous circulation in the resuscitation of patients with cardiac arrest secondary to massive pulmonary embolism.
Thrombolysis during cardiopulmonary resuscitation in fulminant pulmonary embolism: A review
TLDR
From the few existing studies, it can be inferred that thrombolysis may be efficacious and safe for patients with FPE who need CPR, however, a clinical trial is required to provide evidence of value for sound clinical decision-making.
Tenecteplase and Return of Spontaneous Circulation After Refractory Cardiopulmonary Arrest
TLDR
Tenecteplase is a recently developed reengineered isomer of tissue plasminogen activator that possesses many properties of the ideal cardiac arrest thrombolytic agent and is compatible with most other advanced cardiac life support medications.
Pulmonary embolism as a cause of cardiac arrest: presentation and outcome.
TLDR
Thrombolysis should be attempted to achieve return of spontaneous circulation and probably better outcome of patients with cardiac arrest after PE admitted to the emergency department of an urban tertiary care hospital.
Neurologically normal survival after fibrinolysis during prolonged cardiac arrest: case report and discussion.
TLDR
The case of a 28-year-old woman with a pulmonary embolism who developed return of pulses following the administration of tissue plasminogen activator after 38 minutes of pulseless electrical activity cardiac arrest is reported.
...
1
2
3
4
5
...